Study of the Inhibitory Effect of Antibodies Against C3 Complement Component in a Rat Model of Traumatic Brain Injury

 
PIIS102872210002623-0-1
DOI10.31857/S102872210002623-0
Publication type Article
Status Published
Authors
Affiliation:
Affiliation:
Affiliation:
Affiliation:
Affiliation:
Affiliation:
Affiliation:
Journal nameRossiiskii immunologicheskii zhurnal
EditionVolume 12 Issue 4
Pages641-643
Abstract

  

Keywords
Received28.01.2019
Publication date31.01.2019
Cite   Download pdf To download PDF you should sign in
Размещенный ниже текст является ознакомительной версией и может не соответствовать печатной

views: 955

Readers community rating: votes 0

1. Brennan F. H., Lee J. D., Ruitenberg M. J., Woodruff T. M. Therapeutic targeting of complement to modify disease course and improve outcomes in neurological conditions // Semin Immunol. 2016. 28(3). P. 292–308.

2. Alawieh A., Tomlinson S. Injury site-specifi c targeting of complement inhibitors for treating stroke // Immunol. Rev. 2016. Vol. 274 (1). P. 270–280.

3. Alawieh A., Elvington A., Zhu H., Yu J., Kindy M. S., Atkinson C., Tomlinson S., Modulation of post-stroke degenerative and regenerative processes and subacute protection by site-targeted inhibition of the alternative pathway of complement //J Neuroinfl ammation. 2015. Vol.12. P. 247–259.

4. Mastellos D. C., Reis E. S., Yancopoulou D., Hajishengallis G., Ricklin D., Lambris J. D. From orphan drugs to adopted therapies: Advancing C3-targeted intervention to the clinical stage // Immunobiology. 2016. Oct. Vol.221(10).P.1046–57.

Система Orphus

Loading...
Up